65 related articles for article (PubMed ID: 1842347)
1. 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.
Nielsen HK; Jørgensen JO; Brixen K; Møller N; Charles P; Christensen JS
Growth Regul; 1991 Dec; 1(4):153-9. PubMed ID: 1842347
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
3. Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GH-deficient adults.
Hubina E; Lakatos P; Kovács L; Szabolcs I; Rácz K; Tóth M; Szucs N; Góth MI
Calcif Tissue Int; 2004 Jan; 74(1):55-9. PubMed ID: 14508626
[TBL] [Abstract][Full Text] [Related]
4. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
J Clin Endocrinol Metab; 1990 Jan; 70(1):207-14. PubMed ID: 2294131
[TBL] [Abstract][Full Text] [Related]
5. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.
Kanzaki S; Hosoda K; Moriwake T; Tanaka H; Kubo T; Inoue M; Higuchi J; Yamaji T; Seino Y
J Clin Endocrinol Metab; 1992 Oct; 75(4):1104-9. PubMed ID: 1400878
[TBL] [Abstract][Full Text] [Related]
6. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
7. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
Amato G; Izzo G; La Montagna G; Bellastella A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
[TBL] [Abstract][Full Text] [Related]
8. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
9. [Changes in osteocalcin serum levels in children with growth hormone deficiency during substitution therapy].
Muzsnai A; Péter F; Tarján G; Holló I
Orv Hetil; 1994 Feb; 135(6):291-4. PubMed ID: 8309685
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short stature.
Markowitz ME; DiMartino-Nardi J; Gasparini F; Fishman K; Rosen JF; Saenger P
J Clin Endocrinol Metab; 1989 Aug; 69(2):420-5. PubMed ID: 2787800
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin.
Nielsen HK; Brixen K; Kassem M; Charles P; Mosekilde L
J Clin Endocrinol Metab; 1992 Jun; 74(6):1410-4. PubMed ID: 1592888
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels of intact molecular osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy].
Seino Y; Kanzaki S; Kubo T; Hibi I; Tanaka T; Suwa S; Tachibana K; Okuno A; Niimi H; Tsuchiya Y
Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1063-74. PubMed ID: 7859886
[TBL] [Abstract][Full Text] [Related]
13. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
[TBL] [Abstract][Full Text] [Related]
14. The nocturnal increase in growth hormone is not the cause of the nocturnal increase in serum osteocalcin.
Ebeling PR; Butler PC; Eastell R; Rizza RA; Riggs BL
J Clin Endocrinol Metab; 1991 Aug; 73(2):368-72. PubMed ID: 1677363
[TBL] [Abstract][Full Text] [Related]
15. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
Johansen JS; Jensen SB; Riis BJ; Rasmussen L; Zachmann M; Christiansen C
J Clin Endocrinol Metab; 1990 Jul; 71(1):122-6. PubMed ID: 2370291
[TBL] [Abstract][Full Text] [Related]
16. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
Kohno H; Murakami Y; Kodaira T
J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.
Antoniazzi F; Radetti G; Zamboni G; Gambaro G; Adami S; Tatò L
Bone Miner; 1993 May; 21(2):151-6. PubMed ID: 8358252
[TBL] [Abstract][Full Text] [Related]
18. Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH.
Nielsen HK; Jørgensen JO; Brixen K; Christiansen JS
Calcif Tissue Int; 1991 Feb; 48(2):82-7. PubMed ID: 2013017
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.
Holl RW; Schwarz U; Schauwecker P; Benz R; Veldhuis JD; Heinze E
J Clin Endocrinol Metab; 1993 Jul; 77(1):216-20. PubMed ID: 8325945
[TBL] [Abstract][Full Text] [Related]
20. Low urinary growth hormone values in patients with Turner's syndrome.
Kohno H; Honda S
J Clin Endocrinol Metab; 1992 Mar; 74(3):619-22. PubMed ID: 1740496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
